Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 5, 2022BloodOpen Access

A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAsim SahaIndian Council of Medical ResearchSHSharon L. HyzyBiogen (United States)TLTahirih L. LamotheCasma Therapeutics (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Saha et al. (2022) studied this question.

synapsesocial.com/papers/6a840918191c426ca972f482https://doi.org/10.1182/blood.2021012366
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation2019 · 51 citations
  2. 2Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease2020 · 906 citations
  3. 3Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice2010 · 77 citations
  4. 4Design and Synthesis of Tesirine, a Clinical Antibody–Drug Conjugate Pyrrolobenzodiazepine Dimer Payload2016 · 168 citations
  5. 5The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia2017 · 111 citations